Phase I/II Trial for Patients with Advanced Hematologic Malignancies Undergoing Myeloablative Allogeneic HCT with a T Cell Depleted Graft with Infusion of Conventional T Cells and Regulatory T Cells

Please use this identifier to cite or link to this item: http://scholars.ntou.edu.tw/handle/123456789/1320

Title:	Phase I/II Trial for Patients with Advanced Hematologic Malignancies Undergoing Myeloablative Allogeneic HCT with a T Cell Depleted Graft with Infusion of Conventional T Cells and Regulatory T Cells
Authors:	Meyer, E. Laport, G. G. Tantsura, I. Tang, S. W. Sahaf, B. Rangarajan, K. Armstrong, R. Tate, K. Tudisco, C. Sheehan, K. Arai, S. Johnston, L. Muffly, L. Lowsky, R. Rezvani, A. Wen-Kai Weng Miklos, D. Negrin, R. S.
Issue Date:	Mar-2018
Journal Volume:	24
Journal Issue:	3
Source:	Biology of Blood and Marrow Transplantation
URI:	http://scholars.ntou.edu.tw/handle/123456789/1320
ISSN:	1083-8791
DOI:	://WOS:000425476000186
Appears in Collections:	河海工程學系

Show full item record

Last Week
0

Last month
0

checked on Oct 13, 2022

Check

DSpace CRIS